Chuy's Holdings Statistics
Total Valuation
Ardent Health has a market cap or net worth of $1.70 billion. The enterprise value is $3.43 billion.
| Market Cap | 1.70B |
| Enterprise Value | 3.43B |
Important Dates
The last earnings date was Tuesday, August 5, 2025, after market close.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Ardent Health has 143.11 million shares outstanding. The number of shares has increased by 11.20% in one year.
| Current Share Class | 143.11M |
| Shares Outstanding | 143.11M |
| Shares Change (YoY) | +11.20% |
| Shares Change (QoQ) | +0.58% |
| Owned by Insiders (%) | 1.24% |
| Owned by Institutions (%) | 19.48% |
| Float | 24.47M |
Valuation Ratios
The trailing PE ratio is 6.55 and the forward PE ratio is 6.05.
| PE Ratio | 6.55 |
| Forward PE | 6.05 |
| PS Ratio | 0.27 |
| Forward PS | 0.26 |
| PB Ratio | 1.36 |
| P/TBV Ratio | 5.67 |
| P/FCF Ratio | 15.74 |
| P/OCF Ratio | 5.63 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.89, with an EV/FCF ratio of 31.70.
| EV / Earnings | 13.45 |
| EV / Sales | 0.55 |
| EV / EBITDA | 5.89 |
| EV / EBIT | 7.93 |
| EV / FCF | 31.70 |
Financial Position
The company has a current ratio of 2.13, with a Debt / Equity ratio of 1.38.
| Current Ratio | 2.13 |
| Quick Ratio | 1.57 |
| Debt / Equity | 1.38 |
| Debt / EBITDA | 2.70 |
| Debt / FCF | 21.04 |
| Interest Coverage | 7.58 |
Financial Efficiency
Return on equity (ROE) is 24.32% and return on invested capital (ROIC) is 7.37%.
| Return on Equity (ROE) | 24.32% |
| Return on Assets (ROA) | 5.61% |
| Return on Invested Capital (ROIC) | 7.37% |
| Return on Capital Employed (ROCE) | 10.43% |
| Revenue Per Employee | $248,941 |
| Profits Per Employee | $10,235 |
| Employee Count | 24,900 |
| Asset Turnover | 1.29 |
| Inventory Turnover | 23.44 |
Taxes
In the past 12 months, Ardent Health has paid $78.94 million in taxes.
| Income Tax | 78.94M |
| Effective Tax Rate | 18.77% |
Stock Price Statistics
The stock price has decreased by -25.45% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -25.45% |
| 50-Day Moving Average | 12.74 |
| 200-Day Moving Average | 14.47 |
| Relative Strength Index (RSI) | 52.20 |
| Average Volume (20 Days) | 550,285 |
Short Selling Information
The latest short interest is 1.93 million, so 1.35% of the outstanding shares have been sold short.
| Short Interest | 1.93M |
| Short Previous Month | 1.66M |
| Short % of Shares Out | 1.35% |
| Short % of Float | 7.87% |
| Short Ratio (days to cover) | 5.60 |
Income Statement
In the last 12 months, Ardent Health had revenue of $6.20 billion and earned $254.86 million in profits. Earnings per share was $1.82.
| Revenue | 6.20B |
| Gross Profit | 3.58B |
| Operating Income | 432.32M |
| Pretax Income | n/a |
| Net Income | 254.86M |
| EBITDA | 582.46M |
| EBIT | 432.32M |
| Earnings Per Share (EPS) | $1.82 |
Balance Sheet
The company has $548.20 million in cash and $2.27 billion in debt, giving a net cash position of -$1.73 billion or -$12.07 per share.
| Cash & Cash Equivalents | 548.20M |
| Total Debt | 2.27B |
| Net Cash | -1.73B |
| Net Cash Per Share | -$12.07 |
| Equity (Book Value) | 1.65B |
| Book Value Per Share | 8.77 |
| Working Capital | 996.24M |
Cash Flow
In the last 12 months, operating cash flow was $301.98 million and capital expenditures -$193.85 million, giving a free cash flow of $108.13 million.
| Operating Cash Flow | 301.98M |
| Capital Expenditures | -193.85M |
| Free Cash Flow | 108.13M |
| FCF Per Share | $0.76 |
Margins
Gross margin is 57.76%, with operating and profit margins of 6.97% and 4.11%.
| Gross Margin | 57.76% |
| Operating Margin | 6.97% |
| Pretax Margin | 6.78% |
| Profit Margin | 4.11% |
| EBITDA Margin | 9.40% |
| EBIT Margin | 6.97% |
| FCF Margin | 1.74% |
Dividends & Yields
Ardent Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.20% |
| Shareholder Yield | -11.20% |
| Earnings Yield | 14.98% |
| FCF Yield | 6.35% |
Analyst Forecast
The average price target for Ardent Health is $20.12, which is 69.22% higher than the current price. The consensus rating is "Buy".
| Price Target | $20.12 |
| Price Target Difference | 69.22% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ardent Health has an Altman Z-Score of 2.29 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.29 |
| Piotroski F-Score | 6 |